Compare $ATYR vs $KYNB | Chartloom

Compare

$ATYR vs $KYNB

aTyr Pharma Inc · Kyntra Bio Inc

ATYR

aTyr Pharma Inc

KYNB

Kyntra Bio Inc

Compare $ATYR vs $KYNB

Comparing aTyr Pharma Inc and Kyntra Bio Inc

ATYRaTyr Pharma Inc

KYNBKyntra Bio Inc

ATYRaTyr Pharma Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.1%

YTD performance

-67.6%

52W performance

-75.4%

FCF yield

-227.1%

KYNBKyntra Bio Inc

Market cap

$25M

P/E (TTM)

0.14x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.52x

Rev growth (TTM)

-91.4%

YTD performance

-33.3%

52W performance

-46.4%

FCF yield

-153.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATYR

KYNB

Detailed metrics comparison

ATYR

aTyr Pharma Inc

KYNB

Kyntra Bio Inc

Market Cap

ATYR$24M

KYNB$25M

Enterprise Value

ATYR$9M

KYNB$-26M

Price

ATYR$0.25

KYNB$6.11

P/E Ratio

ATYRN/A

KYNB0.14x

P/S Ratio

ATYR127.05x

KYNB5.36x

EV/Sales

ATYR44.92x

KYNB-5.61x

EV/EBITDA

ATYR0.00x

KYNB0.00x

P/B Ratio

ATYR0.58x

KYNB0.97x

P/FCF Ratio

ATYRN/A

KYNBN/A

EV/FCF

ATYR-0.16x

KYNB0.68x

PEG Ratio

ATYRN/A

KYNBN/A

Forward P/E (NTM)

ATYRN/A

KYNBN/A

Forward P/S (NTM)

ATYRN/A

KYNB3.52x

Revenue (TTM)

ATYR$190K

KYNB$5M

Revenue Growth (YoY)

ATYR-19.1%

KYNB-91.4%

Forward Rev Growth

ATYR2461.0%

KYNB21.6%

Gross Margin (TTM)

ATYR0.0%

KYNB6.3%

Operating Margin (TTM)

ATYR0.0%

KYNB0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

KYNB-1083.7%

Net Margin (TTM)

ATYR-20898.4%

KYNB3967.8%

FCF Margin (TTM)

ATYR-28852.1%

KYNB-824.4%

Net Income (TTM)

ATYR$-40M

KYNB$183M

FCF (TTM)

ATYR$-55M

KYNB$-38M

EPS (TTM)

ATYR$0.00

KYNB$45.25

ROE (TTM)

ATYR-9962.0%

KYNB-29091.0%

ROA (TTM)

ATYR-7441.0%

KYNB156.8%

ROIC (TTM)

ATYR-9817.0%

KYNB-25645.0%

Cash

ATYR$16M

KYNB$51M

Debt

ATYR$554K

KYNB$0

Net Cash/Debt

ATYR$16M

KYNB$51M

Current Ratio (TTM)

ATYR5.12x

KYNB2.69x

Quick Ratio (TTM)

ATYR5.08x

KYNB2.57x

Debt/Equity (TTM)

ATYR0.01x

KYNB0.59x

Debt/Assets (TTM)

ATYR0.0%

KYNB0.0%

Interest Coverage (TTM)

ATYRN/A

KYNBN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

KYNB0.00x

Beta

ATYR0.99

KYNB1.07

52W Performance

ATYR-75.4%

KYNB-46.4%

YTD Performance

ATYR-67.6%

KYNB-33.3%

% from 52W High

ATYR-78.0%

KYNB-47.6%

% from 52W Low

ATYR0.1%

KYNB8.7%

Asset Turnover (TTM)

ATYR0.00x

KYNB0.05x

FCF Yield (TTM)

ATYR-227.1%

KYNB-153.8%

Earnings Yield (TTM)

ATYR-164.5%

KYNB740.3%

Dividend Yield (TTM)

ATYRN/A

KYNBN/A

Rule of 40

ATYR-28,871.3

KYNB-915.8

EV/GP/RG

ATYRN/A

KYNBN/A

Ticker research

View ATYR research View KYNB research

Metric	ATYR aTyr Pharma Inc	KYNB Kyntra Bio Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$9M	$-26M
Price	$0.25	$6.11
P/E Ratio	N/A	0.14x
P/S Ratio	127.05x	5.36x
EV/Sales	44.92x	-5.61x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	0.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.52x
Revenue & Growth
Revenue (TTM)	$190K	$5M
Revenue Growth (YoY)	-19.1%	-91.4%
Forward Rev Growth	2461.0%	21.6%
Profitability
Gross Margin (TTM)	0.0%	6.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	-1083.7%
Net Margin (TTM)	-20898.4%	3967.8%
FCF Margin (TTM)	-28852.1%	-824.4%
Net Income (TTM)	$-40M	$183M
FCF (TTM)	$-55M	$-38M
EPS (TTM)	$0.00	$45.25
ROE (TTM)	-9962.0%	-29091.0%
ROA (TTM)	-7441.0%	156.8%
ROIC (TTM)	-9817.0%	-25645.0%
Financial Health
Cash	$16M	$51M
Debt	$554K	$0
Net Cash/Debt	$16M	$51M
Current Ratio (TTM)	5.12x	2.69x
Quick Ratio (TTM)	5.08x	2.57x
Debt/Equity (TTM)	0.01x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	1.07
52W Performance	-75.4%	-46.4%
YTD Performance	-67.6%	-33.3%
% from 52W High	-78.0%	-47.6%
% from 52W Low	0.1%	8.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-227.1%	-153.8%
Earnings Yield (TTM)	-164.5%	740.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	-915.8
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View KYNB research

Valuation

P/E Ratio

KYNB

0.14x

P/S Ratio

KYNB

5.36x

ATYR

127.05x

EV/FCF

ATYR

-0.16x

KYNB

0.68x

Growth & revenue

Revenue Growth TTM

ATYR

-19.1%

KYNB

-91.4%

Forward Revenue Growth

ATYR

2461.0%

KYNB

21.6%

Profitability & performance

Gross Margin

KYNB

6.3%

ATYR

0.0%

ROE

ATYR

-9962.0%

KYNB

-29091.0%

FCF Yield %

KYNB

-153.8%

ATYR

-227.1%

52-Week Performance

KYNB

-46.4%

ATYR

-75.4%

Detailed metrics comparison

ATYR

aTyr Pharma Inc

KYNB

Kyntra Bio Inc

Market Cap

ATYR$24M

KYNB$25M

Enterprise Value

ATYR$9M

KYNB$-26M

Price

ATYR$0.25

KYNB$6.11

P/E Ratio

ATYRN/A

KYNB0.14x

P/S Ratio

ATYR127.05x

KYNB5.36x

EV/Sales

ATYR44.92x

KYNB-5.61x

EV/EBITDA

ATYR0.00x

KYNB0.00x

P/B Ratio

ATYR0.58x

KYNB0.97x

P/FCF Ratio

ATYRN/A

KYNBN/A

EV/FCF

ATYR-0.16x

KYNB0.68x

PEG Ratio

ATYRN/A

KYNBN/A

Forward P/E (NTM)

ATYRN/A

KYNBN/A

Forward P/S (NTM)

ATYRN/A

KYNB3.52x

Revenue (TTM)

ATYR$190K

KYNB$5M

Revenue Growth (YoY)

ATYR-19.1%

KYNB-91.4%

Forward Rev Growth

ATYR2461.0%

KYNB21.6%

Gross Margin (TTM)

ATYR0.0%

KYNB6.3%

Operating Margin (TTM)

ATYR0.0%

KYNB0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

KYNB-1083.7%

Net Margin (TTM)

ATYR-20898.4%

KYNB3967.8%

FCF Margin (TTM)

ATYR-28852.1%

KYNB-824.4%

Net Income (TTM)

ATYR$-40M

KYNB$183M

FCF (TTM)

ATYR$-55M

KYNB$-38M

EPS (TTM)

ATYR$0.00

KYNB$45.25

ROE (TTM)

ATYR-9962.0%

KYNB-29091.0%

ROA (TTM)

ATYR-7441.0%

KYNB156.8%

ROIC (TTM)

ATYR-9817.0%

KYNB-25645.0%

Cash

ATYR$16M

KYNB$51M

Debt

ATYR$554K

KYNB$0

Net Cash/Debt

ATYR$16M

KYNB$51M

Current Ratio (TTM)

ATYR5.12x

KYNB2.69x

Quick Ratio (TTM)

ATYR5.08x

KYNB2.57x

Debt/Equity (TTM)

ATYR0.01x

KYNB0.59x

Debt/Assets (TTM)

ATYR0.0%

KYNB0.0%

Interest Coverage (TTM)

ATYRN/A

KYNBN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

KYNB0.00x

Beta

ATYR0.99

KYNB1.07

52W Performance

ATYR-75.4%

KYNB-46.4%

YTD Performance

ATYR-67.6%

KYNB-33.3%

% from 52W High

ATYR-78.0%

KYNB-47.6%

% from 52W Low

ATYR0.1%

KYNB8.7%

Asset Turnover (TTM)

ATYR0.00x

KYNB0.05x

FCF Yield (TTM)

ATYR-227.1%

KYNB-153.8%

Earnings Yield (TTM)

ATYR-164.5%

KYNB740.3%

Dividend Yield (TTM)

ATYRN/A

KYNBN/A

Rule of 40

ATYR-28,871.3

KYNB-915.8

EV/GP/RG

ATYRN/A

KYNBN/A

Ticker research

View ATYR research View KYNB research

Metric	ATYR aTyr Pharma Inc	KYNB Kyntra Bio Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$9M	$-26M
Price	$0.25	$6.11
P/E Ratio	N/A	0.14x
P/S Ratio	127.05x	5.36x
EV/Sales	44.92x	-5.61x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	0.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	0.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.52x
Revenue & Growth
Revenue (TTM)	$190K	$5M
Revenue Growth (YoY)	-19.1%	-91.4%
Forward Rev Growth	2461.0%	21.6%
Profitability
Gross Margin (TTM)	0.0%	6.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	-1083.7%
Net Margin (TTM)	-20898.4%	3967.8%
FCF Margin (TTM)	-28852.1%	-824.4%
Net Income (TTM)	$-40M	$183M
FCF (TTM)	$-55M	$-38M
EPS (TTM)	$0.00	$45.25
ROE (TTM)	-9962.0%	-29091.0%
ROA (TTM)	-7441.0%	156.8%
ROIC (TTM)	-9817.0%	-25645.0%
Financial Health
Cash	$16M	$51M
Debt	$554K	$0
Net Cash/Debt	$16M	$51M
Current Ratio (TTM)	5.12x	2.69x
Quick Ratio (TTM)	5.08x	2.57x
Debt/Equity (TTM)	0.01x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	1.07
52W Performance	-75.4%	-46.4%
YTD Performance	-67.6%	-33.3%
% from 52W High	-78.0%	-47.6%
% from 52W Low	0.1%	8.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-227.1%	-153.8%
Earnings Yield (TTM)	-164.5%	740.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	-915.8
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View KYNB research